Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Saha, Krishanu  [Clear All Filters]
2024
Cappabianca D, Pham D, Forsberg MH, Bugel M, Tommasi A, Lauer A, Vidugiriene J, Hrdlicka B, McHale A, Sodji Q, et al. Metabolic priming of GD2 -CAR T cells during manufacturing promotes memory phenotypes while enhancing persistence. bioRxiv. 2024.
2023
Logun M, Colonna MB, Mueller KP, Ventarapragada D, Rodier R, Tondepu C, Piscopo NJ, Das A, Chvatal S, Hayes HB, et al. Label-free in vitro assays predict the potency of anti-disialoganglioside chimeric antigen receptor T-cell products. Cytotherapy. 2023.
Kabra M, Shahi PK, Wang Y, Sinha D, Spillane A, Newby GA, Saxena S, Tong Y, Chang Y, Abdeen AA, et al. Nonviral base editing of KCNJ13 mutation preserves vision in a model of inherited retinal channelopathy. J Clin Invest. 2023.
Molugu K, Khajanchi N, Lazzarotto CR, Tsai SQ, Saha K. Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells. CRISPR J. 2023.
2016
Li M, Zhao H, Ananiev GE, Musser M, Ness KH, Maglaque DL, Saha K, Bhattacharyya A, Zhao X. Establishment of reporter lines for detecting fragile X mental retardation (FMR1) gene reactivation in human neural cells. Stem Cells. 2016.
2013
Gajbhiye V, Escalante L, Chen G, Laperle A, Zheng Q, Steyer B, Gong S, Saha K. Drug-loaded nanoparticles induce gene expression in human pluripotent stem cell derivatives. Nanoscale. 2013.